Revising risk stratification in mechanically ventilated ICU patients: the longitudinal European BioVent study
L. Boeck (Basel, Switzerland), H. Pargger (Basel, Switzerland), P. Schellongowski (Vienna, Austria), C. Luyt (Paris, France), M. Maggiorini (Zürich, Switzerland), K. Jahn (Basel, Switzerland), J. Chastre (Paris, France), R. Lötscher (Liestal, Switzerland), E. Bucher (Basel, Switzerland), N. Cueni (Basel, Switzerland), M. Siegemund (Basel, Switzerland), T. Staudinger (Vienna, Austria), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Boeck (Basel, Switzerland), H. Pargger (Basel, Switzerland), P. Schellongowski (Vienna, Austria), C. Luyt (Paris, France), M. Maggiorini (Zürich, Switzerland), K. Jahn (Basel, Switzerland), J. Chastre (Paris, France), R. Lötscher (Liestal, Switzerland), E. Bucher (Basel, Switzerland), N. Cueni (Basel, Switzerland), M. Siegemund (Basel, Switzerland), T. Staudinger (Vienna, Austria), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland). Revising risk stratification in mechanically ventilated ICU patients: the longitudinal European BioVent study. 3778
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: